nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—ABCB1—Levothyroxine—hypothyroidism	0.0579	0.28	CbGbCtD
Carvedilol—ABCB1—Liothyronine—hypothyroidism	0.0579	0.28	CbGbCtD
Carvedilol—ABCB1—Liotrix—hypothyroidism	0.0565	0.273	CbGbCtD
Carvedilol—CYP3A4—Levothyroxine—hypothyroidism	0.0347	0.168	CbGbCtD
Carvedilol—GJA1—seminiferous tubule of testis—hypothyroidism	0.03	0.104	CbGeAlD
Carvedilol—ADRB3—brown adipose tissue—hypothyroidism	0.0168	0.0583	CbGeAlD
Carvedilol—Clotting—Liotrix—hypothyroidism	0.00845	0.03	CcSEcCtD
Carvedilol—VCAM1—tongue—hypothyroidism	0.00838	0.0291	CbGeAlD
Carvedilol—HIF1A—nerve—hypothyroidism	0.00825	0.0287	CbGeAlD
Carvedilol—NPPB—adrenal cortex—hypothyroidism	0.0053	0.0184	CbGeAlD
Carvedilol—NPPB—heart—hypothyroidism	0.00512	0.0178	CbGeAlD
Carvedilol—Angina pectoris—Liothyronine—hypothyroidism	0.00511	0.0182	CcSEcCtD
Carvedilol—Fluid overload—Liotrix—hypothyroidism	0.00485	0.0173	CcSEcCtD
Carvedilol—NPPB—cardiovascular system—hypothyroidism	0.00484	0.0168	CbGeAlD
Carvedilol—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00461	0.0164	CcSEcCtD
Carvedilol—Myocardial infarction—Liothyronine—hypothyroidism	0.00458	0.0163	CcSEcCtD
Carvedilol—Wheezing—Dextrothyroxine—hypothyroidism	0.00399	0.0142	CcSEcCtD
Carvedilol—Wheezing—Levothyroxine—hypothyroidism	0.00399	0.0142	CcSEcCtD
Carvedilol—Coagulopathy—Liotrix—hypothyroidism	0.00388	0.0138	CcSEcCtD
Carvedilol—NPPB—blood—hypothyroidism	0.00382	0.0133	CbGeAlD
Carvedilol—SELE—adrenal cortex—hypothyroidism	0.00358	0.0124	CbGeAlD
Carvedilol—SELE—heart—hypothyroidism	0.00346	0.012	CbGeAlD
Carvedilol—VCAM1—adrenal cortex—hypothyroidism	0.00329	0.0114	CbGeAlD
Carvedilol—SELE—cardiovascular system—hypothyroidism	0.00327	0.0113	CbGeAlD
Carvedilol—VCAM1—heart—hypothyroidism	0.00318	0.0111	CbGeAlD
Carvedilol—Creatinine increased—Liotrix—hypothyroidism	0.00317	0.0113	CcSEcCtD
Carvedilol—HIF1A—adrenal cortex—hypothyroidism	0.00317	0.011	CbGeAlD
Carvedilol—Hypertension—Liothyronine—hypothyroidism	0.00315	0.0112	CcSEcCtD
Carvedilol—GJA1—adrenal cortex—hypothyroidism	0.00307	0.0107	CbGeAlD
Carvedilol—HIF1A—heart—hypothyroidism	0.00306	0.0106	CbGeAlD
Carvedilol—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00305	0.0109	CcSEcCtD
Carvedilol—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00305	0.0109	CcSEcCtD
Carvedilol—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00305	0.0109	CcSEcCtD
Carvedilol—Cardiac failure—Levothyroxine—hypothyroidism	0.00305	0.0109	CcSEcCtD
Carvedilol—VCAM1—cardiovascular system—hypothyroidism	0.003	0.0104	CbGeAlD
Carvedilol—GJA1—heart—hypothyroidism	0.00297	0.0103	CbGeAlD
Carvedilol—Affect lability—Levothyroxine—hypothyroidism	0.00293	0.0104	CcSEcCtD
Carvedilol—Affect lability—Dextrothyroxine—hypothyroidism	0.00293	0.0104	CcSEcCtD
Carvedilol—Wheezing—Liotrix—hypothyroidism	0.00293	0.0104	CcSEcCtD
Carvedilol—Tachycardia—Liothyronine—hypothyroidism	0.00291	0.0103	CcSEcCtD
Carvedilol—SELE—pituitary gland—hypothyroidism	0.00289	0.01	CbGeAlD
Carvedilol—HIF1A—cardiovascular system—hypothyroidism	0.00289	0.01	CbGeAlD
Carvedilol—Fluid retention—Liotrix—hypothyroidism	0.00287	0.0102	CcSEcCtD
Carvedilol—Blood urea increased—Liotrix—hypothyroidism	0.00285	0.0101	CcSEcCtD
Carvedilol—CYP1A2—urine—hypothyroidism	0.00284	0.00987	CbGeAlD
Carvedilol—Cardiac arrest—Levothyroxine—hypothyroidism	0.00283	0.0101	CcSEcCtD
Carvedilol—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00283	0.0101	CcSEcCtD
Carvedilol—Mood swings—Levothyroxine—hypothyroidism	0.00282	0.01	CcSEcCtD
Carvedilol—Mood swings—Dextrothyroxine—hypothyroidism	0.00282	0.01	CcSEcCtD
Carvedilol—GJA1—cardiovascular system—hypothyroidism	0.0028	0.00974	CbGeAlD
Carvedilol—Hypotension—Liothyronine—hypothyroidism	0.00279	0.0099	CcSEcCtD
Carvedilol—Dehydration—Levothyroxine—hypothyroidism	0.00277	0.00985	CcSEcCtD
Carvedilol—Dehydration—Dextrothyroxine—hypothyroidism	0.00277	0.00985	CcSEcCtD
Carvedilol—Lightheadedness—Liotrix—hypothyroidism	0.0027	0.0096	CcSEcCtD
Carvedilol—CYP2C9—urine—hypothyroidism	0.0027	0.00937	CbGeAlD
Carvedilol—NDUFC2—adrenal cortex—hypothyroidism	0.00267	0.00929	CbGeAlD
Carvedilol—VCAM1—pituitary gland—hypothyroidism	0.00266	0.00924	CbGeAlD
Carvedilol—HIF1A—gonad—hypothyroidism	0.00262	0.00911	CbGeAlD
Carvedilol—NDUFC2—heart—hypothyroidism	0.00259	0.00898	CbGeAlD
Carvedilol—SELE—adrenal gland—hypothyroidism	0.00258	0.00897	CbGeAlD
Carvedilol—SELE—blood—hypothyroidism	0.00258	0.00897	CbGeAlD
Carvedilol—HIF1A—pituitary gland—hypothyroidism	0.00256	0.00889	CbGeAlD
Carvedilol—CYP2E1—urine—hypothyroidism	0.00256	0.00888	CbGeAlD
Carvedilol—GJA1—gonad—hypothyroidism	0.00255	0.00884	CbGeAlD
Carvedilol—Sweating increased—Dextrothyroxine—hypothyroidism	0.00251	0.00891	CcSEcCtD
Carvedilol—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00251	0.00891	CcSEcCtD
Carvedilol—Angina pectoris—Levothyroxine—hypothyroidism	0.00251	0.00891	CcSEcCtD
Carvedilol—Sweating increased—Levothyroxine—hypothyroidism	0.00251	0.00891	CcSEcCtD
Carvedilol—SELE—thyroid gland—hypothyroidism	0.00249	0.00866	CbGeAlD
Carvedilol—Swelling—Liotrix—hypothyroidism	0.00248	0.00883	CcSEcCtD
Carvedilol—GJA1—pituitary gland—hypothyroidism	0.00248	0.00862	CbGeAlD
Carvedilol—NDUFC2—cardiovascular system—hypothyroidism	0.00244	0.00848	CbGeAlD
Carvedilol—VEGFA—adrenal cortex—hypothyroidism	0.00243	0.00842	CbGeAlD
Carvedilol—SELE—female gonad—hypothyroidism	0.00241	0.00836	CbGeAlD
Carvedilol—VCAM1—adrenal gland—hypothyroidism	0.00238	0.00825	CbGeAlD
Carvedilol—VCAM1—blood—hypothyroidism	0.00238	0.00825	CbGeAlD
Carvedilol—Renal failure acute—Liotrix—hypothyroidism	0.00237	0.00844	CcSEcCtD
Carvedilol—Body temperature increased—Liothyronine—hypothyroidism	0.00236	0.00838	CcSEcCtD
Carvedilol—VEGFA—heart—hypothyroidism	0.00235	0.00815	CbGeAlD
Carvedilol—Weight decreased—Levothyroxine—hypothyroidism	0.00233	0.00828	CcSEcCtD
Carvedilol—Weight decreased—Dextrothyroxine—hypothyroidism	0.00233	0.00828	CcSEcCtD
Carvedilol—Renal impairment—Liotrix—hypothyroidism	0.0023	0.00818	CcSEcCtD
Carvedilol—VCAM1—thyroid gland—hypothyroidism	0.00229	0.00796	CbGeAlD
Carvedilol—HIF1A—adrenal gland—hypothyroidism	0.00229	0.00794	CbGeAlD
Carvedilol—HIF1A—blood—hypothyroidism	0.00229	0.00794	CbGeAlD
Carvedilol—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00226	0.00804	CcSEcCtD
Carvedilol—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00226	0.00804	CcSEcCtD
Carvedilol—Myocardial infarction—Levothyroxine—hypothyroidism	0.00225	0.008	CcSEcCtD
Carvedilol—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00225	0.008	CcSEcCtD
Carvedilol—Hypoglycaemia—Liotrix—hypothyroidism	0.00225	0.00798	CcSEcCtD
Carvedilol—Cardiac failure—Liotrix—hypothyroidism	0.00225	0.00798	CcSEcCtD
Carvedilol—Cerebrovascular accident—Liotrix—hypothyroidism	0.00224	0.00795	CcSEcCtD
Carvedilol—GJA1—adrenal gland—hypothyroidism	0.00222	0.0077	CbGeAlD
Carvedilol—VCAM1—female gonad—hypothyroidism	0.00222	0.00769	CbGeAlD
Carvedilol—NDUFC2—gonad—hypothyroidism	0.00222	0.00769	CbGeAlD
Carvedilol—HIF1A—thyroid gland—hypothyroidism	0.00221	0.00766	CbGeAlD
Carvedilol—NDUFC2—pituitary gland—hypothyroidism	0.00216	0.0075	CbGeAlD
Carvedilol—Affect lability—Liotrix—hypothyroidism	0.00216	0.00767	CcSEcCtD
Carvedilol—GJA1—thyroid gland—hypothyroidism	0.00214	0.00743	CbGeAlD
Carvedilol—SELE—testis—hypothyroidism	0.00214	0.00742	CbGeAlD
Carvedilol—HIF1A—female gonad—hypothyroidism	0.00213	0.0074	CbGeAlD
Carvedilol—Cardiac arrest—Liotrix—hypothyroidism	0.00208	0.00741	CcSEcCtD
Carvedilol—Mood swings—Liotrix—hypothyroidism	0.00208	0.00738	CcSEcCtD
Carvedilol—GJA1—female gonad—hypothyroidism	0.00207	0.00718	CbGeAlD
Carvedilol—CYP3A4—urine—hypothyroidism	0.00206	0.00714	CbGeAlD
Carvedilol—Blood creatinine increased—Liotrix—hypothyroidism	0.00205	0.0073	CcSEcCtD
Carvedilol—Dehydration—Liotrix—hypothyroidism	0.00204	0.00724	CcSEcCtD
Carvedilol—CYP2D6—urine—hypothyroidism	0.00202	0.00703	CbGeAlD
Carvedilol—SELE—liver—hypothyroidism	0.00202	0.00701	CbGeAlD
Carvedilol—Hypokalaemia—Liotrix—hypothyroidism	0.00199	0.00709	CcSEcCtD
Carvedilol—SELE—cerebellum—hypothyroidism	0.00197	0.00685	CbGeAlD
Carvedilol—VCAM1—testis—hypothyroidism	0.00197	0.00682	CbGeAlD
Carvedilol—VEGFA—pituitary gland—hypothyroidism	0.00196	0.00681	CbGeAlD
Carvedilol—NDUFC2—adrenal gland—hypothyroidism	0.00193	0.0067	CbGeAlD
Carvedilol—NDUFC2—blood—hypothyroidism	0.00193	0.0067	CbGeAlD
Carvedilol—ADRB3—female gonad—hypothyroidism	0.0019	0.00658	CbGeAlD
Carvedilol—HIF1A—testis—hypothyroidism	0.00189	0.00657	CbGeAlD
Carvedilol—NDUFC2—thyroid gland—hypothyroidism	0.00186	0.00647	CbGeAlD
Carvedilol—Bronchospasm—Liotrix—hypothyroidism	0.00186	0.00662	CcSEcCtD
Carvedilol—VCAM1—liver—hypothyroidism	0.00186	0.00645	CbGeAlD
Carvedilol—Sweating increased—Liotrix—hypothyroidism	0.00184	0.00656	CcSEcCtD
Carvedilol—Angina pectoris—Liotrix—hypothyroidism	0.00184	0.00656	CcSEcCtD
Carvedilol—GJA1—testis—hypothyroidism	0.00183	0.00637	CbGeAlD
Carvedilol—Bronchitis—Liotrix—hypothyroidism	0.00182	0.00647	CcSEcCtD
Carvedilol—Alopecia—Dextrothyroxine—hypothyroidism	0.00182	0.00647	CcSEcCtD
Carvedilol—Alopecia—Levothyroxine—hypothyroidism	0.00182	0.00647	CcSEcCtD
Carvedilol—NDUFC2—female gonad—hypothyroidism	0.0018	0.00625	CbGeAlD
Carvedilol—HIF1A—liver—hypothyroidism	0.00179	0.00621	CbGeAlD
Carvedilol—Tension—Dextrothyroxine—hypothyroidism	0.00176	0.00626	CcSEcCtD
Carvedilol—Tension—Levothyroxine—hypothyroidism	0.00176	0.00626	CcSEcCtD
Carvedilol—VEGFA—adrenal gland—hypothyroidism	0.00175	0.00608	CbGeAlD
Carvedilol—HIF1A—cerebellum—hypothyroidism	0.00175	0.00606	CbGeAlD
Carvedilol—Nervousness—Dextrothyroxine—hypothyroidism	0.00174	0.00619	CcSEcCtD
Carvedilol—Nervousness—Levothyroxine—hypothyroidism	0.00174	0.00619	CcSEcCtD
Carvedilol—GJA1—liver—hypothyroidism	0.00173	0.00602	CbGeAlD
Carvedilol—Weight decreased—Liotrix—hypothyroidism	0.00171	0.00609	CcSEcCtD
Carvedilol—GJA1—cerebellum—hypothyroidism	0.00169	0.00588	CbGeAlD
Carvedilol—VEGFA—thyroid gland—hypothyroidism	0.00169	0.00587	CbGeAlD
Carvedilol—Acute coronary syndrome—Liotrix—hypothyroidism	0.00166	0.00592	CcSEcCtD
Carvedilol—Renal failure—Liotrix—hypothyroidism	0.00166	0.0059	CcSEcCtD
Carvedilol—Myocardial infarction—Liotrix—hypothyroidism	0.00166	0.00588	CcSEcCtD
Carvedilol—Angioedema—Levothyroxine—hypothyroidism	0.00164	0.00583	CcSEcCtD
Carvedilol—Angioedema—Dextrothyroxine—hypothyroidism	0.00164	0.00583	CcSEcCtD
Carvedilol—VEGFA—female gonad—hypothyroidism	0.00163	0.00567	CbGeAlD
Carvedilol—NDUFC2—testis—hypothyroidism	0.0016	0.00554	CbGeAlD
Carvedilol—Palpitations—Levothyroxine—hypothyroidism	0.00159	0.00564	CcSEcCtD
Carvedilol—Palpitations—Dextrothyroxine—hypothyroidism	0.00159	0.00564	CcSEcCtD
Carvedilol—Convulsion—Levothyroxine—hypothyroidism	0.00155	0.00553	CcSEcCtD
Carvedilol—Convulsion—Dextrothyroxine—hypothyroidism	0.00155	0.00553	CcSEcCtD
Carvedilol—Arthralgia—Dextrothyroxine—hypothyroidism	0.00153	0.00543	CcSEcCtD
Carvedilol—Arthralgia—Levothyroxine—hypothyroidism	0.00153	0.00543	CcSEcCtD
Carvedilol—NDUFC2—liver—hypothyroidism	0.00151	0.00524	CbGeAlD
Carvedilol—Hypoaesthesia—Liotrix—hypothyroidism	0.00151	0.00536	CcSEcCtD
Carvedilol—Confusional state—Dextrothyroxine—hypothyroidism	0.00148	0.00525	CcSEcCtD
Carvedilol—Confusional state—Levothyroxine—hypothyroidism	0.00148	0.00525	CcSEcCtD
Carvedilol—NDUFC2—cerebellum—hypothyroidism	0.00147	0.00512	CbGeAlD
Carvedilol—VEGFA—testis—hypothyroidism	0.00145	0.00503	CbGeAlD
Carvedilol—Shock—Levothyroxine—hypothyroidism	0.00144	0.00512	CcSEcCtD
Carvedilol—Shock—Dextrothyroxine—hypothyroidism	0.00144	0.00512	CcSEcCtD
Carvedilol—Tachycardia—Dextrothyroxine—hypothyroidism	0.00143	0.00508	CcSEcCtD
Carvedilol—Tachycardia—Levothyroxine—hypothyroidism	0.00143	0.00508	CcSEcCtD
Carvedilol—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00142	0.00503	CcSEcCtD
Carvedilol—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00142	0.00503	CcSEcCtD
Carvedilol—VEGFA—liver—hypothyroidism	0.00137	0.00475	CbGeAlD
Carvedilol—Alopecia—Liotrix—hypothyroidism	0.00134	0.00476	CcSEcCtD
Carvedilol—VEGFA—cerebellum—hypothyroidism	0.00134	0.00464	CbGeAlD
Carvedilol—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00133	0.00474	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00133	0.00474	CcSEcCtD
Carvedilol—Insomnia—Levothyroxine—hypothyroidism	0.00132	0.00471	CcSEcCtD
Carvedilol—Insomnia—Dextrothyroxine—hypothyroidism	0.00132	0.00471	CcSEcCtD
Carvedilol—Dyspnoea—Levothyroxine—hypothyroidism	0.00131	0.00464	CcSEcCtD
Carvedilol—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00131	0.00464	CcSEcCtD
Carvedilol—Flatulence—Liotrix—hypothyroidism	0.0013	0.00462	CcSEcCtD
Carvedilol—Tension—Liotrix—hypothyroidism	0.00129	0.0046	CcSEcCtD
Carvedilol—Nervousness—Liotrix—hypothyroidism	0.00128	0.00456	CcSEcCtD
Carvedilol—Fatigue—Dextrothyroxine—hypothyroidism	0.00126	0.00449	CcSEcCtD
Carvedilol—Fatigue—Levothyroxine—hypothyroidism	0.00126	0.00449	CcSEcCtD
Carvedilol—Vision blurred—Liotrix—hypothyroidism	0.00124	0.00442	CcSEcCtD
Carvedilol—XDH—liver—hypothyroidism	0.00122	0.00423	CbGeAlD
Carvedilol—Feeling abnormal—Levothyroxine—hypothyroidism	0.00121	0.00429	CcSEcCtD
Carvedilol—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00121	0.00429	CcSEcCtD
Carvedilol—Angioedema—Liotrix—hypothyroidism	0.00121	0.00429	CcSEcCtD
Carvedilol—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0012	0.00426	CcSEcCtD
Carvedilol—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0012	0.00426	CcSEcCtD
Carvedilol—Syncope—Liotrix—hypothyroidism	0.00118	0.00421	CcSEcCtD
Carvedilol—Palpitations—Liotrix—hypothyroidism	0.00117	0.00415	CcSEcCtD
Carvedilol—Urticaria—Dextrothyroxine—hypothyroidism	0.00116	0.00413	CcSEcCtD
Carvedilol—Urticaria—Levothyroxine—hypothyroidism	0.00116	0.00413	CcSEcCtD
Carvedilol—Loss of consciousness—Liotrix—hypothyroidism	0.00116	0.00412	CcSEcCtD
Carvedilol—Abdominal pain—Levothyroxine—hypothyroidism	0.00116	0.00411	CcSEcCtD
Carvedilol—Body temperature increased—Levothyroxine—hypothyroidism	0.00116	0.00411	CcSEcCtD
Carvedilol—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00116	0.00411	CcSEcCtD
Carvedilol—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00116	0.00411	CcSEcCtD
Carvedilol—Convulsion—Liotrix—hypothyroidism	0.00114	0.00406	CcSEcCtD
Carvedilol—Hypertension—Liotrix—hypothyroidism	0.00114	0.00405	CcSEcCtD
Carvedilol—Chest pain—Liotrix—hypothyroidism	0.00112	0.00399	CcSEcCtD
Carvedilol—Arthralgia—Liotrix—hypothyroidism	0.00112	0.00399	CcSEcCtD
Carvedilol—ADRB1—heart—hypothyroidism	0.00111	0.00387	CbGeAlD
Carvedilol—Confusional state—Liotrix—hypothyroidism	0.00109	0.00386	CcSEcCtD
Carvedilol—Oedema—Liotrix—hypothyroidism	0.00108	0.00383	CcSEcCtD
Carvedilol—Anaphylactic shock—Liotrix—hypothyroidism	0.00108	0.00383	CcSEcCtD
Carvedilol—Infection—Liotrix—hypothyroidism	0.00107	0.0038	CcSEcCtD
Carvedilol—Shock—Liotrix—hypothyroidism	0.00106	0.00377	CcSEcCtD
Carvedilol—Tachycardia—Liotrix—hypothyroidism	0.00105	0.00374	CcSEcCtD
Carvedilol—ADRB1—cardiovascular system—hypothyroidism	0.00105	0.00365	CbGeAlD
Carvedilol—Asthenia—Levothyroxine—hypothyroidism	0.00105	0.00373	CcSEcCtD
Carvedilol—Asthenia—Dextrothyroxine—hypothyroidism	0.00105	0.00373	CcSEcCtD
Carvedilol—Hyperhidrosis—Liotrix—hypothyroidism	0.00104	0.0037	CcSEcCtD
Carvedilol—Pruritus—Dextrothyroxine—hypothyroidism	0.00104	0.00368	CcSEcCtD
Carvedilol—Pruritus—Levothyroxine—hypothyroidism	0.00104	0.00368	CcSEcCtD
Carvedilol—Anorexia—Liotrix—hypothyroidism	0.00103	0.00365	CcSEcCtD
Carvedilol—Hypotension—Liotrix—hypothyroidism	0.00101	0.00358	CcSEcCtD
Carvedilol—Diarrhoea—Levothyroxine—hypothyroidism	0.001	0.00356	CcSEcCtD
Carvedilol—Diarrhoea—Dextrothyroxine—hypothyroidism	0.001	0.00356	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000981	0.00349	CcSEcCtD
Carvedilol—Insomnia—Liotrix—hypothyroidism	0.000974	0.00346	CcSEcCtD
Carvedilol—Paraesthesia—Liotrix—hypothyroidism	0.000967	0.00344	CcSEcCtD
Carvedilol—Dyspnoea—Liotrix—hypothyroidism	0.00096	0.00341	CcSEcCtD
Carvedilol—Decreased appetite—Liotrix—hypothyroidism	0.000936	0.00333	CcSEcCtD
Carvedilol—Vomiting—Levothyroxine—hypothyroidism	0.000931	0.00331	CcSEcCtD
Carvedilol—Vomiting—Dextrothyroxine—hypothyroidism	0.000931	0.00331	CcSEcCtD
Carvedilol—Fatigue—Liotrix—hypothyroidism	0.000929	0.0033	CcSEcCtD
Carvedilol—Rash—Dextrothyroxine—hypothyroidism	0.000923	0.00328	CcSEcCtD
Carvedilol—Rash—Levothyroxine—hypothyroidism	0.000923	0.00328	CcSEcCtD
Carvedilol—Dermatitis—Levothyroxine—hypothyroidism	0.000922	0.00328	CcSEcCtD
Carvedilol—Dermatitis—Dextrothyroxine—hypothyroidism	0.000922	0.00328	CcSEcCtD
Carvedilol—Constipation—Liotrix—hypothyroidism	0.000921	0.00327	CcSEcCtD
Carvedilol—Headache—Dextrothyroxine—hypothyroidism	0.000917	0.00326	CcSEcCtD
Carvedilol—Headache—Levothyroxine—hypothyroidism	0.000917	0.00326	CcSEcCtD
Carvedilol—Feeling abnormal—Liotrix—hypothyroidism	0.000887	0.00315	CcSEcCtD
Carvedilol—Gastrointestinal pain—Liotrix—hypothyroidism	0.000881	0.00313	CcSEcCtD
Carvedilol—ADRA1A—heart—hypothyroidism	0.000881	0.00306	CbGeAlD
Carvedilol—Nausea—Dextrothyroxine—hypothyroidism	0.00087	0.00309	CcSEcCtD
Carvedilol—Nausea—Levothyroxine—hypothyroidism	0.00087	0.00309	CcSEcCtD
Carvedilol—ADRA2C—adrenal cortex—hypothyroidism	0.000868	0.00301	CbGeAlD
Carvedilol—Urticaria—Liotrix—hypothyroidism	0.000856	0.00304	CcSEcCtD
Carvedilol—Abdominal pain—Liotrix—hypothyroidism	0.000851	0.00303	CcSEcCtD
Carvedilol—Body temperature increased—Liotrix—hypothyroidism	0.000851	0.00303	CcSEcCtD
Carvedilol—KCNH2—heart—hypothyroidism	0.00085	0.00295	CbGeAlD
Carvedilol—ADRA2C—heart—hypothyroidism	0.000839	0.00291	CbGeAlD
Carvedilol—ADRA1A—cardiovascular system—hypothyroidism	0.000831	0.00288	CbGeAlD
Carvedilol—KCNH2—cardiovascular system—hypothyroidism	0.000802	0.00279	CbGeAlD
Carvedilol—Hypersensitivity—Liotrix—hypothyroidism	0.000793	0.00282	CcSEcCtD
Carvedilol—Asthenia—Liotrix—hypothyroidism	0.000773	0.00275	CcSEcCtD
Carvedilol—Pruritus—Liotrix—hypothyroidism	0.000762	0.00271	CcSEcCtD
Carvedilol—Diarrhoea—Liotrix—hypothyroidism	0.000737	0.00262	CcSEcCtD
Carvedilol—CYP1A1—heart—hypothyroidism	0.000718	0.00249	CbGeAlD
Carvedilol—Dizziness—Liotrix—hypothyroidism	0.000712	0.00253	CcSEcCtD
Carvedilol—KCNH2—pituitary gland—hypothyroidism	0.000711	0.00247	CbGeAlD
Carvedilol—ADRA2C—pituitary gland—hypothyroidism	0.000701	0.00243	CbGeAlD
Carvedilol—CYP2C9—heart—hypothyroidism	0.000691	0.0024	CbGeAlD
Carvedilol—Vomiting—Liotrix—hypothyroidism	0.000685	0.00243	CcSEcCtD
Carvedilol—Rash—Liotrix—hypothyroidism	0.000679	0.00241	CcSEcCtD
Carvedilol—Dermatitis—Liotrix—hypothyroidism	0.000678	0.00241	CcSEcCtD
Carvedilol—Headache—Liotrix—hypothyroidism	0.000675	0.0024	CcSEcCtD
Carvedilol—ADRA2A—heart—hypothyroidism	0.00067	0.00232	CbGeAlD
Carvedilol—ADRA1A—adrenal gland—hypothyroidism	0.000657	0.00228	CbGeAlD
Carvedilol—ADRA1A—blood—hypothyroidism	0.000657	0.00228	CbGeAlD
Carvedilol—CYP2C9—cardiovascular system—hypothyroidism	0.000652	0.00226	CbGeAlD
Carvedilol—Nausea—Liotrix—hypothyroidism	0.00064	0.00227	CcSEcCtD
Carvedilol—KCNH2—adrenal gland—hypothyroidism	0.000635	0.0022	CbGeAlD
Carvedilol—KCNH2—blood—hypothyroidism	0.000635	0.0022	CbGeAlD
Carvedilol—PTGS1—heart—hypothyroidism	0.000631	0.00219	CbGeAlD
Carvedilol—ADRA2C—adrenal gland—hypothyroidism	0.000626	0.00217	CbGeAlD
Carvedilol—ADRA2C—blood—hypothyroidism	0.000626	0.00217	CbGeAlD
Carvedilol—CYP2E1—cardiovascular system—hypothyroidism	0.000618	0.00215	CbGeAlD
Carvedilol—PTGS1—cardiovascular system—hypothyroidism	0.000595	0.00207	CbGeAlD
Carvedilol—KCNH2—female gonad—hypothyroidism	0.000592	0.00205	CbGeAlD
Carvedilol—ADRA2C—female gonad—hypothyroidism	0.000584	0.00203	CbGeAlD
Carvedilol—ADRA2A—gonad—hypothyroidism	0.000573	0.00199	CbGeAlD
Carvedilol—ADRA2A—pituitary gland—hypothyroidism	0.000559	0.00194	CbGeAlD
Carvedilol—CYP1A2—blood—hypothyroidism	0.000543	0.00189	CbGeAlD
Carvedilol—CYP1A1—blood—hypothyroidism	0.000536	0.00186	CbGeAlD
Carvedilol—PTGS1—pituitary gland—hypothyroidism	0.000527	0.00183	CbGeAlD
Carvedilol—KCNH2—testis—hypothyroidism	0.000525	0.00182	CbGeAlD
Carvedilol—CYP1A2—thyroid gland—hypothyroidism	0.000524	0.00182	CbGeAlD
Carvedilol—ADRA2C—testis—hypothyroidism	0.000518	0.0018	CbGeAlD
Carvedilol—CYP1A1—thyroid gland—hypothyroidism	0.000517	0.0018	CbGeAlD
Carvedilol—CYP2C9—blood—hypothyroidism	0.000516	0.00179	CbGeAlD
Carvedilol—ADRA1A—liver—hypothyroidism	0.000514	0.00178	CbGeAlD
Carvedilol—ADRA1A—cerebellum—hypothyroidism	0.000502	0.00174	CbGeAlD
Carvedilol—CYP1A1—female gonad—hypothyroidism	0.0005	0.00174	CbGeAlD
Carvedilol—ADRA2A—adrenal gland—hypothyroidism	0.0005	0.00174	CbGeAlD
Carvedilol—ADRA2A—blood—hypothyroidism	0.0005	0.00173	CbGeAlD
Carvedilol—ADRA2C—liver—hypothyroidism	0.00049	0.0017	CbGeAlD
Carvedilol—CYP2E1—adrenal gland—hypothyroidism	0.000489	0.0017	CbGeAlD
Carvedilol—CYP2E1—blood—hypothyroidism	0.000489	0.0017	CbGeAlD
Carvedilol—KCNH2—cerebellum—hypothyroidism	0.000485	0.00168	CbGeAlD
Carvedilol—ADRA2A—thyroid gland—hypothyroidism	0.000482	0.00167	CbGeAlD
Carvedilol—ADRA2C—cerebellum—hypothyroidism	0.000478	0.00166	CbGeAlD
Carvedilol—CYP2E1—thyroid gland—hypothyroidism	0.000472	0.00164	CbGeAlD
Carvedilol—PTGS1—adrenal gland—hypothyroidism	0.000471	0.00164	CbGeAlD
Carvedilol—PTGS1—blood—hypothyroidism	0.000471	0.00163	CbGeAlD
Carvedilol—ADRA2A—female gonad—hypothyroidism	0.000466	0.00162	CbGeAlD
Carvedilol—PTGS1—thyroid gland—hypothyroidism	0.000454	0.00158	CbGeAlD
Carvedilol—PTGS1—female gonad—hypothyroidism	0.000439	0.00152	CbGeAlD
Carvedilol—CYP1A2—liver—hypothyroidism	0.000425	0.00148	CbGeAlD
Carvedilol—CYP1A1—liver—hypothyroidism	0.000419	0.00146	CbGeAlD
Carvedilol—ADRA2A—testis—hypothyroidism	0.000413	0.00143	CbGeAlD
Carvedilol—CYP2E1—testis—hypothyroidism	0.000404	0.0014	CbGeAlD
Carvedilol—CYP2C9—liver—hypothyroidism	0.000403	0.0014	CbGeAlD
Carvedilol—CYP3A4—blood—hypothyroidism	0.000393	0.00137	CbGeAlD
Carvedilol—PTGS1—testis—hypothyroidism	0.000389	0.00135	CbGeAlD
Carvedilol—CYP2D6—blood—hypothyroidism	0.000387	0.00134	CbGeAlD
Carvedilol—ABCB1—adrenal cortex—hypothyroidism	0.000386	0.00134	CbGeAlD
Carvedilol—CYP2E1—liver—hypothyroidism	0.000382	0.00133	CbGeAlD
Carvedilol—ADRA2A—cerebellum—hypothyroidism	0.000382	0.00133	CbGeAlD
Carvedilol—CYP2E1—cerebellum—hypothyroidism	0.000373	0.0013	CbGeAlD
Carvedilol—ABCB1—heart—hypothyroidism	0.000373	0.0013	CbGeAlD
Carvedilol—CYP2D6—female gonad—hypothyroidism	0.000361	0.00125	CbGeAlD
Carvedilol—ABCB1—cardiovascular system—hypothyroidism	0.000352	0.00122	CbGeAlD
Carvedilol—CYP2D6—testis—hypothyroidism	0.00032	0.00111	CbGeAlD
Carvedilol—ABCB1—gonad—hypothyroidism	0.000319	0.00111	CbGeAlD
Carvedilol—ABCB1—pituitary gland—hypothyroidism	0.000312	0.00108	CbGeAlD
Carvedilol—CYP3A4—liver—hypothyroidism	0.000308	0.00107	CbGeAlD
Carvedilol—CYP2D6—liver—hypothyroidism	0.000303	0.00105	CbGeAlD
Carvedilol—CYP2D6—cerebellum—hypothyroidism	0.000296	0.00103	CbGeAlD
Carvedilol—ABCB1—adrenal gland—hypothyroidism	0.000278	0.000967	CbGeAlD
Carvedilol—ABCB1—blood—hypothyroidism	0.000278	0.000967	CbGeAlD
Carvedilol—ABCB1—thyroid gland—hypothyroidism	0.000269	0.000933	CbGeAlD
Carvedilol—ABCB1—female gonad—hypothyroidism	0.00026	0.000901	CbGeAlD
Carvedilol—ABCB1—testis—hypothyroidism	0.00023	0.000799	CbGeAlD
Carvedilol—ABCB1—liver—hypothyroidism	0.000218	0.000756	CbGeAlD
Carvedilol—ABCB1—cerebellum—hypothyroidism	0.000213	0.000738	CbGeAlD
Carvedilol—ADRB2—Signaling by GPCR—TSHB—hypothyroidism	8.03e-05	0.000359	CbGpPWpGaD
Carvedilol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.01e-05	0.000358	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	7.86e-05	0.000351	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	7.78e-05	0.000348	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—IYD—hypothyroidism	7.68e-05	0.000343	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	7.63e-05	0.000341	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	7.62e-05	0.000341	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.61e-05	0.000341	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—IYD—hypothyroidism	7.61e-05	0.00034	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—TSHB—hypothyroidism	7.6e-05	0.00034	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—TSHR—hypothyroidism	7.6e-05	0.00034	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.55e-05	0.000338	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.49e-05	0.000335	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	7.48e-05	0.000334	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	7.48e-05	0.000334	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	7.45e-05	0.000333	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—POMC—hypothyroidism	7.4e-05	0.000331	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	7.31e-05	0.000327	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	7.31e-05	0.000327	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SH2B3—hypothyroidism	7.28e-05	0.000326	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SH2B3—hypothyroidism	7.27e-05	0.000325	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IGF1—hypothyroidism	7.12e-05	0.000318	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	7.09e-05	0.000317	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ATP5O—hypothyroidism	6.93e-05	0.00031	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	6.92e-05	0.00031	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CLTC—hypothyroidism	6.91e-05	0.000309	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—POMC—hypothyroidism	6.88e-05	0.000307	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	6.8e-05	0.000304	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	6.8e-05	0.000304	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	6.66e-05	0.000298	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	6.64e-05	0.000297	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	6.64e-05	0.000297	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—VAV3—hypothyroidism	6.58e-05	0.000294	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ATP5O—hypothyroidism	6.53e-05	0.000292	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TPO—hypothyroidism	6.51e-05	0.000291	CbGpPWpGaD
Carvedilol—CYP2D6—Biological oxidations—POMC—hypothyroidism	6.51e-05	0.000291	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—IYD—hypothyroidism	6.5e-05	0.000291	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ATP5O—hypothyroidism	6.47e-05	0.000289	CbGpPWpGaD
Carvedilol—CYP2C9—Biological oxidations—POMC—hypothyroidism	6.45e-05	0.000288	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CLTC—hypothyroidism	6.29e-05	0.000282	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—POMC—hypothyroidism	6.26e-05	0.00028	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	6.24e-05	0.000279	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	6.21e-05	0.000278	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	6.18e-05	0.000277	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	6.17e-05	0.000276	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	6.17e-05	0.000276	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CLTC—hypothyroidism	6.16e-05	0.000275	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TPO—hypothyroidism	6.14e-05	0.000274	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—POMC—hypothyroidism	6.13e-05	0.000274	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	6.11e-05	0.000273	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TPO—hypothyroidism	6.08e-05	0.000272	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—VAV3—hypothyroidism	6.07e-05	0.000271	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TRH—hypothyroidism	5.97e-05	0.000267	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—POMC—hypothyroidism	5.96e-05	0.000267	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	5.85e-05	0.000261	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	5.83e-05	0.000261	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	5.8e-05	0.000259	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	5.73e-05	0.000256	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	5.71e-05	0.000255	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.64e-05	0.000252	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—VAV3—hypothyroidism	5.53e-05	0.000247	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ATP5O—hypothyroidism	5.53e-05	0.000247	CbGpPWpGaD
Carvedilol—CYP1A2—Biological oxidations—POMC—hypothyroidism	5.51e-05	0.000246	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	5.51e-05	0.000246	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	5.48e-05	0.000245	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TRH—hypothyroidism	5.44e-05	0.000243	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—POMC—hypothyroidism	5.42e-05	0.000242	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—VAV3—hypothyroidism	5.41e-05	0.000242	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PRL—hypothyroidism	5.4e-05	0.000242	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TRH—hypothyroidism	5.39e-05	0.000241	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PRL—hypothyroidism	5.39e-05	0.000241	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—TSHB—hypothyroidism	5.37e-05	0.00024	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—TSHB—hypothyroidism	5.36e-05	0.00024	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—IGF1—hypothyroidism	5.34e-05	0.000239	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AVP—hypothyroidism	5.33e-05	0.000238	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	5.32e-05	0.000238	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TRH—hypothyroidism	5.32e-05	0.000238	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	5.32e-05	0.000238	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	5.31e-05	0.000237	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	5.28e-05	0.000236	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AVP—hypothyroidism	5.21e-05	0.000233	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TPO—hypothyroidism	5.2e-05	0.000232	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	5.12e-05	0.000229	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	5.09e-05	0.000228	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	5.07e-05	0.000227	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	5.04e-05	0.000225	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TRH—hypothyroidism	5.04e-05	0.000225	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—VAV3—hypothyroidism	5.02e-05	0.000225	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—IYD—hypothyroidism	5.02e-05	0.000224	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—VAV3—hypothyroidism	5e-05	0.000224	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—IGF1—hypothyroidism	4.99e-05	0.000223	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—VAV3—hypothyroidism	4.99e-05	0.000223	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	4.98e-05	0.000223	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TRH—hypothyroidism	4.96e-05	0.000222	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	4.93e-05	0.000221	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—VAV3—hypothyroidism	4.91e-05	0.00022	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	4.85e-05	0.000217	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TSHB—hypothyroidism	4.85e-05	0.000217	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TSHR—hypothyroidism	4.85e-05	0.000217	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AVP—hypothyroidism	4.84e-05	0.000216	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.82e-05	0.000215	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.82e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AVP—hypothyroidism	4.81e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	4.8e-05	0.000215	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AVP—hypothyroidism	4.8e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	4.8e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	4.79e-05	0.000214	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	4.78e-05	0.000214	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PIK3C2A—hypothyroidism	4.77e-05	0.000214	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TSHB—hypothyroidism	4.74e-05	0.000212	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	4.74e-05	0.000212	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TSHR—hypothyroidism	4.74e-05	0.000212	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AVP—hypothyroidism	4.73e-05	0.000212	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	4.73e-05	0.000212	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.71e-05	0.000211	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	4.71e-05	0.000211	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	4.65e-05	0.000208	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	4.57e-05	0.000205	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	4.49e-05	0.000201	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	4.49e-05	0.000201	CbGpPWpGaD
Carvedilol—XDH—Metabolism—POMC—hypothyroidism	4.48e-05	0.0002	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	4.48e-05	0.0002	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	4.47e-05	0.0002	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	4.42e-05	0.000198	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	4.42e-05	0.000198	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	4.41e-05	0.000197	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TRH—hypothyroidism	4.4e-05	0.000197	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—TSHB—hypothyroidism	4.36e-05	0.000195	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SH2B3—hypothyroidism	4.32e-05	0.000193	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	4.31e-05	0.000193	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	4.28e-05	0.000192	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ATP5O—hypothyroidism	4.27e-05	0.000191	CbGpPWpGaD
Carvedilol—CYP3A4—Biological oxidations—POMC—hypothyroidism	4.25e-05	0.00019	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SH2B3—hypothyroidism	4.23e-05	0.000189	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	4.16e-05	0.000186	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TRH—hypothyroidism	4.09e-05	0.000183	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	4.06e-05	0.000182	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—IGF1—hypothyroidism	4.05e-05	0.000181	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC5A5—hypothyroidism	4.02e-05	0.00018	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TPO—hypothyroidism	4.01e-05	0.000179	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC5A5—hypothyroidism	4.01e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	4e-05	0.000179	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—TSHB—hypothyroidism	4e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	4e-05	0.000179	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	3.94e-05	0.000176	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	3.92e-05	0.000175	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	3.92e-05	0.000175	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	3.91e-05	0.000175	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	3.89e-05	0.000174	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	3.89e-05	0.000174	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.79e-05	0.00017	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	3.77e-05	0.000169	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—TSHB—hypothyroidism	3.77e-05	0.000169	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	3.65e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	3.65e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	3.64e-05	0.000163	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	3.57e-05	0.00016	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—POMC—hypothyroidism	3.54e-05	0.000158	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	3.53e-05	0.000158	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PRL—hypothyroidism	3.52e-05	0.000157	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	3.51e-05	0.000157	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	3.5e-05	0.000156	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—POMC—hypothyroidism	3.46e-05	0.000155	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3C2A—hypothyroidism	3.36e-05	0.00015	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.32e-05	0.000148	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	3.28e-05	0.000147	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC5A5—hypothyroidism	3.26e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	3.26e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	3.25e-05	0.000145	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	3.22e-05	0.000144	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—POMC—hypothyroidism	3.21e-05	0.000144	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PRL—hypothyroidism	3.21e-05	0.000143	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—POMC—hypothyroidism	3.2e-05	0.000143	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—POMC—hypothyroidism	3.19e-05	0.000143	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	3.19e-05	0.000142	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PRL—hypothyroidism	3.18e-05	0.000142	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—POMC—hypothyroidism	3.14e-05	0.000141	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AVP—hypothyroidism	3.14e-05	0.00014	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PRL—hypothyroidism	3.14e-05	0.00014	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IGF1—hypothyroidism	3.08e-05	0.000138	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IGF1—hypothyroidism	3.07e-05	0.000137	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TSHB—hypothyroidism	3.01e-05	0.000135	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC5A5—hypothyroidism	3e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	2.98e-05	0.000133	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PRL—hypothyroidism	2.97e-05	0.000133	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VAV3—hypothyroidism	2.97e-05	0.000133	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	2.94e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	2.93e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PRL—hypothyroidism	2.92e-05	0.000131	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VAV3—hypothyroidism	2.9e-05	0.00013	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	2.86e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AVP—hypothyroidism	2.86e-05	0.000128	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TSHB—hypothyroidism	2.84e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AVP—hypothyroidism	2.83e-05	0.000127	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC5A5—hypothyroidism	2.83e-05	0.000126	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TSHB—hypothyroidism	2.82e-05	0.000126	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AVP—hypothyroidism	2.8e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	2.75e-05	0.000123	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	2.7e-05	0.000121	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.69e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	2.66e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AVP—hypothyroidism	2.64e-05	0.000118	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AVP—hypothyroidism	2.6e-05	0.000116	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	2.6e-05	0.000116	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PRL—hypothyroidism	2.59e-05	0.000116	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	2.53e-05	0.000113	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	2.51e-05	0.000112	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.48e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	2.42e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PRL—hypothyroidism	2.41e-05	0.000108	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TSHB—hypothyroidism	2.41e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	2.4e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AVP—hypothyroidism	2.31e-05	0.000103	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.26e-05	0.000101	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	2.23e-05	9.97e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AVP—hypothyroidism	2.15e-05	9.61e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.14e-05	9.59e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC5A5—hypothyroidism	2.13e-05	9.51e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.12e-05	9.47e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC5A5—hypothyroidism	2.11e-05	9.43e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—POMC—hypothyroidism	2.1e-05	9.4e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—POMC—hypothyroidism	2.1e-05	9.38e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—POMC—hypothyroidism	2.08e-05	9.32e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	2e-05	8.97e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—POMC—hypothyroidism	1.9e-05	8.49e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—POMC—hypothyroidism	1.88e-05	8.42e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—POMC—hypothyroidism	1.86e-05	8.31e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TSHB—hypothyroidism	1.86e-05	8.31e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF1—hypothyroidism	1.83e-05	8.17e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	1.81e-05	8.1e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.8e-05	8.06e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF1—hypothyroidism	1.79e-05	7.99e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—POMC—hypothyroidism	1.76e-05	7.86e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—POMC—hypothyroidism	1.73e-05	7.74e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—POMC—hypothyroidism	1.71e-05	7.64e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	1.69e-05	7.56e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	1.66e-05	7.44e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.66e-05	7.4e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—POMC—hypothyroidism	1.57e-05	7.01e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—POMC—hypothyroidism	1.54e-05	6.87e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—POMC—hypothyroidism	1.48e-05	6.61e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.48e-05	6.61e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.43e-05	6.39e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.39e-05	6.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.37e-05	6.14e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—POMC—hypothyroidism	1.18e-05	5.28e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—POMC—hypothyroidism	1.11e-05	4.98e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—POMC—hypothyroidism	1.1e-05	4.93e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—POMC—hypothyroidism	9.43e-06	4.22e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—POMC—hypothyroidism	7.27e-06	3.25e-05	CbGpPWpGaD
